Allele loss on chromosome 1p36 in epithelial ovarian cancers

Gynecologic Oncology

Volumn 82, Issue 1, 2001, Pages 94-98

  Alvarez, Angeles A ^a   Lambers, Anouk R ^a   Lancaster, Johnathan M ^a   Maxwell, G Larry ^a   Ali, Shazia ^a   Gumbs, Curtis ^a   Berchuck, Andrew ^a   Futreal, P Andrew ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chromosome 1p36; Loss of heterozygosity; Ovarian cancer

Indexed keywords

TUMOR MARKER;

ALLELE; ARTICLE; CANCER GRADING; CANCER STAGING; CELL DIFFERENTIATION; CHROMOSOME 1P; CHROMOSOME LOSS; CONTROLLED STUDY; FEMALE; GENE INACTIVATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; OVARY CANCER; PATHOGENESIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0034939557     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6175     Document Type: Article

References (32)

1. The p53 tumor suppressor gene frequently is altered in gynecologic cancers
2. Detection of BRCA1 mutations in women with early onset ovarian cancer using the protein truncation test
3. BRCA2 mutations in primary breast and ovarian cancers
4. Managing hereditary ovarian cancer risk
5. Pathogenesis of ovarian cancers
6. Growth and transformation suppressor genes for BH Syrian hamster cells on human chromosomes 1 and 11
7. Suppression of tumourigenicity in human colon carcinoma cells by introduction of normal chromosome 1p36 region
8. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer
9. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma
10. Two distinct regions involved in 1p deletion in human primary breast cancer
11. Allelic imbalance on chromosome 1 in human breast cancer. I. Minisatellite and RFLP analysis
12. Allelic imbalance on chromosome 1 in human breast cancer. II. Microsatellite repeat analysis
13. Loss of heterozygosity at chromosome 1p in different solid human tumours: Association with survival
14. Frequent deletion of chromosome 1p sequences in an aggressive histologic subtype of endometrial cancer
15. Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis
16. Significance of chromosome 1p loss of heterozygosity in neuroblastoma
17. Molecular pathogenesis of malignant gliomas
18. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3
19. Band 1p36 abnormalities and t(1;17) in ovarian carcinoma
20. Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinoma but the gene encoding p73 is unlikely to be the target
21. Frequent deletion of distal chromosome 1p in primary ovarian cancer: A common deletion unit overlaps a region lost in breast cancer and other malignancies
22. Human epithelial ovarian cancer allelotype
23. Molecular genetic changes in human epithelial ovarian malignancies
24. Synergisitc effect of aphidicolin and ethanol on the induction of common fragile sites
25. Identification of chromosomal bands replicating early in the S phase of normal human fibroblasts
26. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas
27. Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers
28. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis
29. Physical mapping and genomic structure of the human TNFR2 gene
30. The FKBP12-rapamycin-binding domain is required for FKBP12-rapamycin-associated protein kinase activity and G1 progression
31. Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycin associated protein
32. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other cancers